13F Data
13F filer · CIK 1799883

5AM Venture Management, LLC

SAN FRANCISCO, CA · filing since Q4 2019 · last filing Aug 14, 2026
Reported value
$287.9M
$-72.3M vs prior
Positions
16
New / sold out
0 / 4
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $93.2M
Top-10 weight
85.6%

Biggest buys vs Q1 2026

No new or increased positions this quarter.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outERASCA INC-3,485,971-100.0%$-56.4M
Sold outCENTESSA PHARMACEUTICALS PLC-580,945-100.0%$-23.1M
Sold outGH RESEARCH PLC-572,665-100.0%$-8.1M
ReducedSURROZEN INC-116,250-30.0%$-3.0M
Sold outRALLYBIO CORP-291,788-100.0%$-2.6M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2019: $464.8MQ1 2020: $323.0MQ2 2020: $456.6MQ3 2020: $380.3MQ4 2020: $296.9MQ1 2021: $555.4MQ2 2021: $397.3MQ3 2021: $492.5MQ4 2021: $532.8MQ1 2022: $457.8MQ2 2022: $404.2MQ3 2022: $522.0MQ4 2022: $372.1MQ1 2023: $391.0MQ2 2023: $401.4MQ3 2023: $347.5MQ4 2023: $377.0MQ1 2024: $446.6MQ2 2024: $447.1MQ3 2024: $484.0MQ4 2024: $419.1MQ1 2025: $264.4MQ2 2025: $260.1MQ3 2025: $273.0MQ4 2025: $318.1MQ1 2026: $360.2MQ2 2026: $287.9M
Q4 2019Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1MAPLIGHT THERAPEUTICS INCCOM950,011$34.0M11.83%
2TYRA BIOSCIENCES INCCOM1,029,298$32.9M11.42%
3ENTRADA THERAPEUTICS INCCOM4,056,379$29.9M10.37%
4PHARVARIS N VCOM797,600$27.6M9.58%
5CAMP4 THERAPEUTICS CORPCOM5,869,091$25.6M8.91%
6ARTIVA BIOTHERAPEUTICS INCCOM2,353,304$22.8M7.93%
7TECTONIC THERAPEUTIC INCCOM606,660$20.9M7.24%
8ZENTALIS PHARMACEUTICALS INCCOM3,947,913$19.1M6.65%
9CELLDEX THERAPEUTICS INC NEWCOM NEW497,270$18.5M6.43%
10EYEPOINT INCCOM NEW1,050,000$15.0M5.22%
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.